标签档案: 专利权

美国专利商标局 Announces a New Initiative to Provide Applicants Additional Time to Petition for Restoring a Right of Priority or Benefit

On June 11, 2020, 美国专利商标局 Director Andrei Iancu authorized an initiative[1] that may apply to an applicant who has filed an earlier foreign patent application[2] or a U.S. provisional patent application[3] 和 has missed the 上 e-year deadline to file a U.S. nonprovisional utility patent application but would still like to obtain the right of the … 继续阅读

美国专利商标局 Provides Form for Claiming 30-Day COVID-19 Extensions

On March 31, 2020, the 美国专利商标局 announced that it is permitting applicants, for delays that are based 上 the 上 going COVID-19 emergency in the United States, to request a 30-day extension of the time allowed to file certain documents 和 to pay certain fees. We provided an explanation of this announcement when it was published. … 继续阅读

鉴于公众利益,违反了FTC对ITC排除令的影响

Imagine a scenario where the International Trade Commission (ITC) finds a respondent infringes a standard essential patent (SEP).  An SEP that was included in a standard based 上 a voluntary promise to license it 上 fair, reasonable, 和 non-discriminatory (FRAND) terms.  What happens when the complainant has breached its FRAND obligation, 和 at the same … 继续阅读

PTO癌症免疫疗法快速通道

In response to President Obama’s National Cancer Moonshot initiative to eliminate cancer, the 美国专利商标局 has launched the “Cancer Immunotherapy Pilot Program.” The Pilot Program provides an accelerated review for applications related to cancer immunotherapy 和 is set to launch in 2016年七月. According to the 美国专利商标局, this initiative:… 继续阅读

High Court Takes 上 Laches 和 专利权

As published by The Daily Journal 上 May 11, 2016. Businesses dread getting letters that make claims of patent infringement. Such letters often raise complex questions of patent law that require specialized advice 和 demand a license fee that eats into company profits. Sometimes, however, the patent owner fails to follow up 上 the letter, 和 … 继续阅读

不合理的特许权使用费率不是游戏问题

尊敬的法官詹姆斯·罗伯特(James L. Robart)最近承担了一项艰巨的任务,即确定摩托罗拉标准必要专利(“ SEP”)的合理且非歧视(“ RAND”)专利使用费率。 Microsoft Corp.诉Motorola,Inc.,2013年美国地区。 LEXIS 60233,编号C10-11823(W.D.Wash.2013年4月25日)。这个决定是在微软和摩托罗拉之间进行了两年的专利战之后做出的。… 继续阅读

有关专利期限调整的最新最终临时规则的注意事项

On April 1, 2013, the U.S. Patent 和 Trademark Office (USPTO) published interim final rules revising several patent term adjustment (PTA) provisions in view of the 友邦保险 Technical Corrections Act of January 14, 2013. 78 Fed. Reg. 19416. The 美国专利商标局’s interim final rules became effective 上 April 1, 2013, 和 apply to any patent granted … 继续阅读

地方法院就子公司拥有的知识产权的终端免责声明划清界限

通过 Michael Febbo 和 丹尼尔·亚努齐(Daniel Yannuzzi) On September 25, 2012, the U.S. District Court for the District of Nevada ruled that the common ownership requirements of a terminal disclaimer were not met when the subject patent 和 its predecessor patent were owned by different wholly owned subsidiaries of a parent company. Takeaways from the case … 继续阅读

Belkin International,Inc.诉Kappos –错综复杂的竞技场中的警示故事当事人间复试

通过 Michael Murphy 和 Martin Bader On Tuesday of last week, the Federal Circuit held that a party bringing a request for inter-partes reexamination may not appeal a decision by the Director of the U.S. Patent 和 Trademark Office that certain prior art does not raise a substantial new question of patentability. See Belkin International, … 继续阅读

CLS银行: The patent eligibility of computerized trading platforms for exchanging obligations

通过  Barry Wilson and 马丁·巴德(Martin Bader),2012年7月9日,美国联邦巡回法院三名法官组成的小组 CLS Bank International诉Alice Corporation (第2011-1301号上诉)("CLS Bank"),根据35 U.S.C.决定了专利资格的案例§101.在一项分割决定中,小组推翻了地区法院’认定三项Alice Corporation专利要求计算机化… 继续阅读

最高法院确认,仿制药制造商可以在专利诉讼中质疑品牌使用代码的描述

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S 566 U.S. ___, 132 S. Ct. 1670 (Apr. 17, 2012) 通过 Nagendra Setty 和 Bill Blonigan The Hatch-Waxman Act Congress designed the Hatch-Waxman Act (codified at 21 U.S.C. § 355(b), (j), (l) 和 35 U.S.C. §§ 156, 271, 和 282) to inspire medical innovation by giving medical-device … 继续阅读

法院在减轻故意侵犯专利的损害赔偿方面发挥更大作用

Bard Peripheral Vascular,Inc.诉W.L.血块&Associates,Inc.(联邦法院,2012年6月14日),作者:马丁·巴德尔(Martin Bader)和比尔·布洛尼根(Bill Blonigan)。戈尔故意侵犯了巴德’的人造血管移植专利。地方法院随后决定将陪审团人数加倍’的1.856亿美元赔偿金。血块… 继续阅读

被告是故意的专利侵权者吗?审判法院必须确定诉讼是否客观合理

通过 Mark McGrath The Federal Circuit’s recent decisions have sought to address a number of issues relating to damages in patent cases. In its recent decision in Bard Peripheral Vascular,Inc.诉W.L.血块& Associates, Inc., No. 2010-1510, ___ F.3d ___ (Fed. Cir. June 14, 2012), available at http://www.cafc. uscourts.gov/images/stories/opinionsorders/ 10-1510.pdf (“Bard”), the Federal … 继续阅读
LexBlog

滚动此页面,单击链接或继续浏览我们的网站,即表示您同意我们按照我们的说明使用Cookie。 Cookie 和 Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored 上 your device in the future, you can find out more 和 adjust your preferences 这里 .

同意